Otsuka Pharmaceutical Development & Commercialization, Inc.

With our focus in neuroscience, nephrology, and digital innovation, OPDC is dedicated to the research and clinical development of products that could have a major impact on human health.

CEO

Kabir Nath, MA, MBA

PRESIDENT & CEO, Otsuka North America Pharmaceutical Business

 

 Kabir has nearly thirty years of broad international biopharmaceutical and medical device experience. He has shaped strategy and delivered results in complex, challenging business environments at country, regional, and global levels.

 

Kabir joined Otsuka in March 2016 to head all commercial operations within our North American pharmaceutical businesses. In March 2020, Kabir was appointed Senior Managing Director, Global Pharmaceutical Business, OPC, with overall operational leadership for the global pharma business, overseeing the regions of North America, Europe, Japan, and the rest of Asia. He continues to oversee the North American business in parallel.

View Bio

EXPLORE

WEBSITE CAREERS NEWS

CONTACT

508 Carnegie Center Dr,
Princeton, NJ 08540

Tel: 1-609-524-6788

Kabir joined Otsuka in March 2016 to head all commercial operations within our North American pharmaceutical businesses. In March 2020, Kabir was appointed Senior Managing Director, Global Pharmaceutical Business, OPC, with overall operational leadership for the global pharma business, overseeing the regions of North America, Europe, Japan, and the rest of Asia. He continues to oversee the North American business in parallel.